Family history of cancer and risk of colorectal cancer in Italy. by Negri, E. et al.
British Joumal ofCancer(1998) 77(1), 174-179
© 1998 Cancer Research Campaign
Family history of cancer and risk of colorectal cancer
in Italy
E Negri', C Braga1, C La Vecchial,2, S Franceschi3, R Filiberti4, M Montella5, F Falcini6, E Conti7 and R Talamini3
'Istituto di Ricerche Farmacologiche 'Mario Negri', 20157 Milan, Italy; 21stituto di Statistica Medica e Biometria, Universita degli Studi di Milano, 20133 Milan,
Italy; 3Servizio di Epidemiologia, Centro di Riferimento Oncologico, 33081 Aviano (PN), Italy; 41stituto Nazionale per la Ricerca sul Cancro, 16132 Genoa, Italy;
51stituto per lo Studio e la Cura dei Tumori 'Senatore Pascale', 80100 Naples, Italy; 6lstituto Oncologico Romagnolo, Ospedale Pierantoni, 47100 Forli, Italy;
71stituto Regina Elena per lo Studio e la Cura dei Tumori, 00100 Rome, Italy
Summary Subjects with a family history of colorectal cancer (CRC) are at increased risk of CRC, but quantification of the risk in different
populations, the possible differences in risk according to localization of the cancer and the association of family history of other cancers with
CRC risk are still open issues. We have therefore analysed data from a multicentric case-control study conducted in six Italian areas between
1992 and 1996 of 1225 incident cases of colon cancer, 728 cases of rectal cancer and 4154 controls admitted for acute conditions to the same
network of hospitals as the cases. Unconditional logistic regression models including terms for gender, age, study centre, years of education
and number of siblings were used to estimate the odds ratios (ORs) of CRC according to various aspects of history of CRC and other cancers
in first-degree relatives. The OR for family history of CRC was 3.2 (95% confidence interval, Cl, 2.5-4.1) for colon cancer and 2.2 (95% Cl
1.6-3.1) for rectal cancer. Colon cancer was significantly associated with a family history of stomach (OR 1.4), bone (OR 2.1) and kidney
(OR 2.3) cancers, while rectal cancer was significantly associated with a family history of lymphomas (OR 2.8). There was a 30% higher risk
of colon and rectal cancer in subjects with a family history of any cancer, excluding intestine. The ORs for family history of CRC were 5.2 for
colon and 6.3 for rectum when the proband's age was below 45 years. The ORs were similar when the affected relative was a parent or a
sibling and in different strata of age of relative(s). For subjects with two or more first-degree relatives with CRC, the risk was 6.9 for the right
colon, 5.8 for the transverse and descending colon, 3.8 for the sigma, 3.2 for the rectosigmoid junction and 1.9 for the rectum. This study
confirms that afamily history of CRC in first-degree relatives increases the risk of both colon and rectal cancer, the association being stronger
at younger ages and for right colon.
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Several hereditary diseases involving colorectal cancer (CRC)
have been described (Lynch et al, 1991). Two major inherited
syndromes have been identified that lead to an extremely high risk
of early-onset CRC. Familial adenomatous polyposis (FAP), an
autosomal dominant condition characterized by a large number
(> 100) of adenomas in the large bowel, has been linked to muta-
tions in the APC (adenomatous polyposis coli) gene on chromo-
some 5q (Scott and Muller, 1993). Another more frequent
syndrome that causes early-onset CRC is hereditary non-polyposis
CRC (HNPCC), in which excesses have also been observed of
cancers of the endometrium, ovary, small intestine, urinary tract,
hepatobiliary system, stomach and pancreas (Lynch et al, 1996).
HNPCC is thought to account for about 1-5% of all CRC cases,
although its incidence may vary in different populations (Lynch et
al, 1996). A small proportion of cancers at other sites can also be
attributed to this genetic condition. Carriers of BRCAJ, the gene
conferring a very high risk of early onset of breast and ovarian
cancer, are at approximately double the risk of CRC compared
with non-carriers (Ford et al, 1994).
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Other susceptibility genes may exist, with lower penetrance but
higher frequency in the population, that might account for other
cases of CRC. Identification of these genes is extremely difficult
as their low penetrance does not give rise to striking familial
aggregations. As not all relatives are carriers and the gene is also
frequent among controls, they can be missed in epidemiological
studies, even if the risk among susceptible subjects is 10-100
times that among non-susceptible subjects (Peto, 1980).
Several epidemiological studies have reported that relatives of
patients with CRC are at an increased risk of developing CRC
(Houlston and Peto, 1996). Most studies, however, have been
conducted in the USA and northern Europe. The frequency of
susceptibility genes varies in different populations. Even within
Italy, the search for HNPCC families in two cancer registries, one
in the north of the country and the other in the south, has brought
to light an apparently different frequency ofthe disease in the two
areas (Modica et al, 1995).
Furthermore, it has been suggested that the association with
family history ofCRC may vary according to the subsite at which
the CRC arises, but few studies have analysed data using a more
detailed division than colon and rectum. Moreover, few studies
have investigated the family history of other cancers in subjects
with CRC. To investigate these issues, we have examined the rela-
tion between risk of CRC and family history of CRC and other
cancers using data from a large multicentric case-control study
conducted in Italy.
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METHODS
A case-control study of cancers of the colon and rectum was
conducted between January 1992 and June 1996 in six Italian areas:
the provinces of Pordenone and Gorizia in north-eastern Italy, the
urban areas ofMilan and Genoa, the Province ofForli, in the north
ofthe country, Latina and the urban area ofNaples in the south. The
general design of the investigation has already been described
(Franceschi et al, 1997). The same structured questionnaire and
coding manual were used in all study centres, and all interviewers
were centrally trained and routinely supervised. Data were checked
centrally for consistency. On average, less than 4% of cases and
controls approached for interview refused to participate.
Cases were 1225 patients (688 men and 537 women) with
histologically confirmed cancer of the colon (International
Classification of Diseases, ICD-9 153.0-153.9; WHO, 1977) and
728 subjects (437 men and 291 women) with cancer ofthe rectum
and rectosigmoidjunction (ICD-9, 154.0 and 154.1; WHO, 1977).
All cases were interviewed within 1 year from diagnosis and did
not have a previous history of cancer. The age range was 23-74
years and the median age was 62 years.
Controls were subjects with no history of cancer, residing in the
same geographical areas and admitted for acute conditions to the
same network ofhospitals as the cases. Controls were not included
if they had been admitted for intestinal or neoplastic diseases. A
total of 4154 controls (2073 men and 2081 women) aged 20-74
years (median age 58 years) was interviewed. They were admitted
to hospital for a wide spectrum of acute conditions, unrelated to
known or likely risk factors for colorectal cancer. Of these, 27%
had traumatic conditions (mostly fractures and sprains), 24% other
orthopaedic disorders (mostly low back pain or disc disorders),
18% had acute surgical conditions, 24% eye diseases and 7% other
miscellaneous diseases, such as ear, nose and throat, skin and
dental conditions.
The questionnaire included information on personal characteris-
tics and habits, education and other socioeconomic factors, general
lifestyle habits, such as smoking, alcohol and coffee consumption,
a validated food-frequency section, physical activity, menstrual
and reproductive history, selected medical conditions, and history
of lifetime use of aspirin and hormone preparations. The subjects
were specifically asked how many sisters and brothers they had,
and whether their parents, siblings, children, grandparents or
spouse had ever had cancer (except non-melanomatous skin
cancer). For each relative with a history of cancer, subjects were
asked to specify whether the relative was still alive at the time of
interview, the current age or the age at death, the site ofthe tumour
and the age at diagnosis. History of cancer in the spouse or grand-
parents was not considered in the present analysis. On account of
recall and classification difficulties, some sites (i.e. colon and
rectum; non-Hodgkin and Hodgkin's lymphomas; and cervix and
corpus uteri) were combined.
Statistical analysis
We estimated the odds ratio (OR) of colon and rectal cancer
according to history of cancer of selected sites in first-degree
relatives by means of unconditional multiple logistic regression
(Breslow and Day, 1980). The models included terms for gender,
age (quinquennia), study centre, years of education and number of
siblings, brothers or sisters according to the cancer site. Cases were
subdivided into five groups, according to the subsite at which the
tumour was localized: (1) right colon (including hepatic flexure,
ICD-9 153.0; the caecum 153.4; the appendix, 153.5; and the
ascending colon, 153.6); (2) transverse anddescending colon (153.1
and 153.2, including the splenic flexure, 153.7); (3) sigmoid colon
(153.3); (4) rectosigmoid junction (154.0); and (5) rectum (154.1).
For410 cases ofcolon cancer, the subsite was multiple orunknown.
RESULTS
Table 1 gives the distribution of cases of colon and rectal cancers
and of controls according to sex, age, centre, education and
number ofsiblings. Cases tended to be somewhatolder, and colon,
but not rectal cases, were more educated than controls; there was
no appreciable difference in the number ofsiblings.
Table 2 shows the number ofcases and controls with ahistory of
selected cancers in first-degree relatives, and the corresponding
ORs for colon and rectal cancers separately and together. Family
history of intestinal cancer was reported by 134 colon cancer
cases, 53 rectal cancer cases and 146 controls. The corresponding
ORs were 3.2 (95% Cl 2.5-4.1) forcolon, 2.2 (95% Cl 1.6-3.1) for
rectal cancer and 2.8 (95% Cl 2.3-3.6) for the two sites together.
There was aborderline significant association ofcolon cancer with
family history of stomach (OR 1.4), bone (OR 2.1) and kidney
(OR 2.3) cancers, while rectal cancer was significantly associated
with a family history of lymphomas (OR 2.8), and for several
other sites the OR was above unity. In most instances, however,
the ORs for colon and rectum were similar, or at least not incom-
patible. There was a 30% increase in risk both for colon and rectal
Table 1 Distribution of 1225 cases of colon cancer, 728 of rectal cancer and
4154 controls by sex, age group, centre, education and number of siblings,
Italy, 1992-96
Characteristic Cancer cases Controls
Colon Rectum
n(%) n(%) n(%)
Sex
Male 688 (56) 437 (60) 2073 (50)
Female 537 (44) 291 (40) 2081 (50)
Age group (years)
< 40 55 (4) 26 (4) 347 (8)
40-49 114 (9) 67 (9) 732 (18)
50-59 321 (27) 197 (27) 1244 (30)
60-69 518 (42) 306 (42) 1356 (33)
70-74 217 (18) 132 (18) 475 (11)
Centre
Pordenone/Gorizia 401 (33) 216 (30) 1358 (33)
Milan 262 (21) 226 (31) 1082 (26)
Genoa 152 (12) 73 (10) 498 (12)
Forli 65 (5) 29 (4) 247 (6)
Latina 228 (19) 108 (15) 582 (14)
Naples 117 (10) 76 (10) 582 (14)
Education (years)
<7 621 (51) 422 (58) 2276 (55)
7-11 331 (27) 181 (25) 1156 (28)
2 12 267 (22) 122 (17) 693 (17)
Number of siblings
0 84 (7) 60 (8) 322 (8)
1 or 2 475 (39) 234 (32) 1471 (35)
3 or 4 330 (27) 206 (28) 1170 (28)
25 334(27) 227(31) 1187 (29)
Some figures do not add up to the total because some values are missing.
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Table 2 Number of cases and odds ratioa (OR) of colon and rectal cancer and corresponding 95% confidence interval (Cl) according to history of selected
cancers in first-degree relatives (Italy, 1993-96)
Site of cancer in relatives Positive family history OR (95% Cl)
Colon Rectum Controls Colon cancer Rectal cancer Colorectal cancer
(n=1232) (n=721) (n=4154)
Oral cavity 13 15 58 0.7 (0.4-1.3) 1.6 (0.9-2.8) 1.0 (0.6-1.6)
Oesophagus 8 2 27 1.0 (0.4-2.2) 0.4 (0.1-1.9) 0.8 (0.4-1.7)
Stomach 83 40 217 1.4(1.0-1.8) 1.1 (0.7-1.5) 1.2 (1.0-1.6)
Intestine 134 53 146 3.2 (2.5-4.1) 2.2 (1.6-3.1) 2.8 (2.3-3.6)
Liver 2 6 26 0.3 (0.1-1.1) 1.4 (0.6-3.4) 0.7 (0.3-1.5)
Gall bladder 1 - 3 0.9 (0.1-9.2) - 0.6 (0.1-5.5)
Pancreas 18 14 56 1.1 (0.6-1.9) 1.5 (0.8-2.8) 1.2 (0.8-1.9)
Larynx 17 11 48 1.3 (0.7-2.3) 1.4 (0.7-2.7) 1.3 (0.8-2.2)
Lung 86 48 252 1.2 (0.9-1.6) 1.1 (0.8-1.6) 1.2 (0.9-1.4)
Bone 12 - 24 2.1 (1.0-4.4) - 1.3 (0.6-2.7)
Melanoma 4 4 9 1.6 (0.5-5.4) 2.5 (0.7-8.4) 2.1 (0.8-5.5)
Breast 58 33 184 1.0 (0.8-1.4) 1.1 (0.7-1.6) 1.0 (0.8-1.3)
Uterus 30 22 89 1.1 (0.7-1.7) 1.5 (0.9-2.4) 1.2 (0.9-1.7)
Ovary 7 6 17 1.5 (0.6-3.6) 2.1 (0.8-5.5) 1.7 (0.8-3.6)
Prostate 17 13 53 1.1 (0.6-1.9) 1.5 (0.8-2.9) 1.3 (0.8-2.0)
Bladder 13 10 42 1.0 (0.5-1.9) 1.5 (0.7-3.1) 1.2 (0.7-2.0)
Kidney 14 3 24 2.3 (1.2-4.6) 0.9 (0.3-3.1) 1.8 (1.0-3.4)
Brain 24 10 65 1.2 (0.8-2.0) 0.9 (0.4-1.7) 1.1 (0.7-1.7)
Thyroid 4 2 10 2.2 (0.7-5.5) 1.5 (0.3-7.4) 1.7 (0.6-4.7)
Lymphomas 4 9 22 0.7 (0.2-1.9) 2.8 (1.3-6.3) 1.4 (0.7-2.8)
Leukaemia 20 9 59 1.2 (0.7-2.0) 0.9 (0.4-1.8) 1.1 (0.7-1.7)
All sites, excluding intestine 433 258 1268 1.3(1.1-1.4) 1.3 (1.1-1.6) 1.3(1.1-1.4)
aEstimates from multiple logistic regression models including terms for age, sex, cl
category are the subjects with no history of each particular cancer in first-degree r
Table 3 Odds ratioa (OR) and 95% confidence interval (Cl) of colorectal
cancer according to history of colorectal cancer in first-degree relatives in
strata of selected covariates
Strata OR (95% Cl)
Colon cancer Rectal cancer Colorectal cancer
Sex
Male 3.6(2.5-5.1) 2.0(1.2-3.2) 2.9 (2.1-4.1)
Female 2.9 (2.0-4.2) 2.5 (1.6-4.0) 2.9 (2.1-4.0)
Age of the proband (years)
<45 5.2 (2.1-13.) 6.3 (1.8-22.) 5.3 (2.3-12.)
45-59 3.3 (2.2-5.0) 2.2 (1.2-3.8) 2.9 (2.0-4.2)
. 60 2.9 (2.1-4.1) 2.0 (1.3-3.2) 2.6 (1.9-3.5)
Centre
Pordenone and Gorizia 3.3 (2.1-5.1) 3.5 (2.1-5.9) 3.4 (2.3-5.1)
Milan 3.0 (1.7-5.1) 1.4(0.7-2.8) 2.3(1.4-3.7)
Genoa 3.4 (1.7-6.8) 2.0 (0.7-5.7) 2.9 (1.5-5.7)
ForR 1.7 (0.6-4.7) 1.8 (0.5-6.8) 1.8 (0.8-4.4)
Latina 4.5(1.6-12.) 2.8(0.8-11.) 3.8 (1.5-9.5)
Naples 4.4 (2.2-8.8) 1.2 (0.4-3.9) 3.3 (1.7-6.3)
Years of education
<7 3.4(2.4-4.9) 2.3(1.4-3.6) 3.0 (2.2-4.1)
.7 3.0 (2.1-4.3) 2.3 (1.4-3.7) 2.8 (2.0-3.9)
aEstimates from multiple logistic regression models including terms for sex,
age, centre, education and number of siblings. Reference category is no
history of colorectal cancer in first-degree relatives.
cancer in subjects with a family history of any cancer, excluding
intestine.
Table 3 presents the ORs ofCRC according to family history of
intestinal cancer in first-degree relatives in strata of sex, age,
entre, education and number of siblings (or sisters or brothers). Reference
elatives.
centre and education. There was a strong interaction with age of
the proband, the OR ofcolon cancerbeing 5.2 below age 45 years,
3.3 between 45 and 59 years and 2.9 above age 60 years. Forrectal
cancer, the corresponding figures were 6.3, 2.2 and 2.0. No clear
differences in risk emerged between strata ofother covariates.
Various aspects of history of intestinal cancer in first-degree
relatives are considered in Table4. Forcolon, but notrectal cancer,
the presence oftwo or more affected relatives implied a substantial
increase in risk (OR 6.2) in comparison to only one affected rela-
tive (OR 3.0). No clear difference in the OR of colon or rectal
canceremerged when the age ofdiagnosis in the youngest relative
was below or over55 years ofage, the ORbeing 2.9 or3.3, respec-
tively, for colon and 2.1 in both strata for rectum. When the
affected relative was a parent of the proband, the OR was 3.2 for
colon, 2.2 for rectum and 3.0 for the two sites together, while the
corresponding ORs foronly siblings affected were 3.0, 2.2 and 2.7.
The OR became 5.4 for colon, 2.0 for rectum and 4.0 for the two
sites combined when both parent(s) and sibling(s) were affected.
Table 5 sets out the risks associated with a family history of
CRC for different subsites of the tumour in the proband. The OR
for CRC family history were 3.4 for the right colon, 3.7 for the
transverse anddescending colon, 2.5 for the sigmoid colon, 2.9 for
the rectosigmoid junction and 2.0 for the rectum; for those with
two or more first-degree relatives affected, the ORs were 6.9, 5.8,
3.8, 3.2 and 1.9 respectively.
DISCUSSION
This study confirms that a family history of intestinal cancer in
first-degree relatives increases the risk of both colon and rectal
cancer by about threefold, the association being stronger at
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Table 4 Number of cases and odds ratioa (OR) of colon and rectal cancer and corresponding 95% confidence interval (Cl) according to various aspects of
history of colorectal cancer in first-degree relatives (Italy, 1993-96)
Number of subjects OR (95% Cl)
Colon Rectum Controls Colon cancer Rectal cancer Colorectal cancer
(n = 1232) (n = 721) (n = 4154)
No family history 1091 675 4008 1b 1b 1b
Number of affected relatives
1 121 50 139 3.0 (2.3-3.9) 2.2 (1.6-3.1) 2.7 (2.2-3.5)
.2 13 3 7 6.2 (2.4-16) 2.2 (0.5-8.5) 4.7 (1.9-11)
Youngest age at diagnosis in relatives (years)
<55 27 11 35 2.9 (1.7-4.9) 2.1 (1.0-4.2) 2.6(1.6-4.1)
.55 100 38 106 3.3 (2.4-4.3) 2.1 (1.5-3.2) 2.8 (2.2-3.7)
Relative(s) affected
Parent(s) 83 30 93 3.2 (2.4-4.4) 2.2 (1.4-3.4) 3.0 (2.2-3.9)
Sibling(s) 46 22 50 3.0 (2.0-4.6) 2.2 (1.3-3.7) 2.7 (1.8-3.9)
Parent(s) and sibling(s) 5 1 3 5.4 (1.2-24) 2.0 (0.2-20.) 4.0 (1.0-17)
aEstimates from multiple logistic regression models including terms for age, sex, centre, education and number of siblings. bReference category.
Table 5 Odds ratioa (OR) and 95% confidence interval (Cl) of colorectal cancer subsitesb according to history of colorectal cancer in first-degree relatives (Italy,
1993-96)
Transverse and Rectosigmoid
Right colon descending colon Sigmoid colon junction Rectum
n OR (95% C) n OR (95% C) n OR (95% C) n OR (95% C) n OR (95% C)
History of colorectal cancer in first-degree relatives
Noc 163 1 165 1 402 1 143 1 532 1
Yes 22 3.4 (2.1-5.4) 23 3.7(2.3-6.0) 40 2.5 (1.7-3.6) 16 2.9 (1.7-5.1) 37 2.0(1.3-2.9)
Number of affected relatives
1 19 3.1 (1.9-5.2) 21 3.6 (2.2-5.9) 37 2.4(1.6-3.6) 15 2.9 (1.7-5.2) 35 2.0 (1.3-2.9)
> 2 3 6.9 (1.7-28) 2 5.8 (1.2-29) 3 3.8 (0.9-15) 1 3.2 (0.4-27) 2 1.9 (0.4-9.6)
aEstimates from multiple logistic regression models including terms for sex, age, centre, education and number of siblings. bThe right colon included the hepatic
flexure (ICD9 153.0), the caecum (ICD9 153.4), the appendix (ICD9 153.5) and the ascending colon (ICD9 153.6); the transverse (ICD9 153.1) and descending
colon (ICD9 153.2) included the splenic flexure (ICD9 153.7); and the other subsites were the sigma (ICD9 153.3), the rectosigmoid junction (154.0) and the
rectum (154.1). cReference category.
younger ages and in the right, transverse and descending colon. A
few associations emerged with family history of various other
cancers, and the OR of CRC was 1.3 for family history of any
cancer, excluding CRC.
This study is based on information reported by the subjects, and
it is therefore conceivable that cases may recall family history of
cancer better than controls. However, recall of cancer history is
generally accurate for first-degree, although less for second-
degree, relatives (Theis et al, 1994). For this reason, we limited
our analysis to first-degree relatives.
Although the use of hospital controls has long been debated
(Breslow and Day, 1980), we carefully excluded possible diag-
noses for controls potentially related to CRC. Moreover, the
hospital setting itself may have improved the comparability of
information on medical history (Paganini-Hill and Ross, 1982);
participation was practically complete, and the catchment areas of
cases and controls were similar. Allowance for major identified
potential confounding factors did notmaterially modify any ofthe
risk estimates.
The major strength and originality ofthis study, however, is the
information on history of cancer at various sites in relatives, and
the consequent possibility of obtaining quantitative estimates of
CRC risk with reference to family aggregation of other cancers.
Additionally, the study was large enough to permit meaningful
evaluation ofthe risk in the subsites ofthe colon and the rectum.
Our findings are in broad agreement with other reports of an
elevated risk ofcolorectal cancer in subjects with a family history
of CRC (Woolf, 1958; Macklin, 1960; Lovett, 1976; Duncan and
Kyle, 1982; Bonelli et al, 1988; Ponz de Leon et al, 1989;
Sondergaard et al, 1991; La Vecchia et al, 1992; St. John et al,
1993; Fuchs et al, 1994; Goldgar et al, 1994; Slattery and Kerber,
1994; Carstensen et al, 1996; Le Marchand et al, 1996). In most
studies, the risk was, as in ours, higher with younger proband age
(Lovett, 1976; Sondergaard et al, 1991; La Vecchia et al, 1992; St
John et al, 1993; Fuchs et al, 1994; Goldgar et al, 1994; Slattery
and Kerber, 1994; Carstensen et al, 1996; Le Marchand et al,
1996). In ajoint analysis of the Nurses' Health Study and Health
Professionals Follow-up Study cohorts, based on 463 cases of
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CRC, the risk conveyed by family history decreased with
increasing age of the proband, coming very close to unity above
age 65 years (Fuchs et al, 1994). In contrast, in the present study,
the risk remained above 2 even over age 65 years, although it was
over 5 below age 45 years. A risk above 2 over age 60 years was
also observed in a comprehensive population-based study of
familial cancer based on the Utah population database (Goldgar et
al, 1994). In that study, as in the present one, the risk was also
elevated for rectal cancer. No appreciable difference in risk
emerged in this study with the age at diagnosis in relatives. Most
studies have not reported on the issue, and thus little information is
available.
In this study, the associations were similar for subjects with a
history of CRC in parents and siblings, thus pointing to an impor-
tant role ofdominant genes (Cannon-Albright et al, 1988; Ponz de
Leon et al, 1992).
It has been suggested that the location of the cancer within the
colon may determine distinct genetic categories of the disease, in
the absence, however, of any quantification of risk (Bufill, 1990).
Further, there are differences in the time trends and sex distribu-
tions of various subsites (Faivre et al, 1989; Devesa and Chow,
1993). Many studies, however, did not find a higher risk for
subjects with a family history in the proximal colon rather than in
the distal colon (St. John et al, 1993; Fuchs et al, 1994; Slattery
and Kerber, 1994); however the definition of proximal varied as
some studies also included transverse colon.
In the present study, when first-degree family history of CRC
was considered as a whole, the risk ofcancer in the right colon was
only moderately higher than that of cancer in the left colon.
However, when analysis was limited to individuals with two or
more relatives with CRC, the risk approached 7 in the right colon,
compared with 4 in the sigmoid colon and 2 in the rectum. These
estimates were based on limited numbers and may be due to
chance. They however suggest that genes with high penetrance
may have a major role in the right colon.
In the Utah population database, moderate but significant
increases of colon cancer risk were observed in subjects with a
first-degree family history of cancers of the breast, uterus, ovary
and prostate (Slattery and Kerber, 1994). Our study found no asso-
ciation with breast cancer, even when analyses were restricted to
early age at diagnosis in the proband or in the relative, while in
subjects below age 50 years the risks for family history ofprostate,
uterine and ovarian cancers were 2.5, 1.4 and 18.6 respectively; the
last estimate, however, was based only on three cases and one
control. One ofthese three cases had the mother and one sister with
ovarian cancer diagnosed at ages 72 and 43 years, respectively,
suggesting an involvement ofthe BRCAI gene (Ford et al, 1994).
No strong associations emerged with other digestive or respira-
tory sites, apart from a borderline significant association of colon
cancer with a family history of stomach cancer and an association
between lymphomas and rectal cancer. A previous study in
northern Italy (La Vecchia et al, 1992) also found an association
with gastric cancer, and the Utah Population Database (Goldgar et
al, 1994) with leukaemias. The associations with bone and kidney
cancer for colon in this study are probably because of misclassifi-
cation of metastases and/or chance.
We report a 30% higherrisk ofCRC in patients reporting a history
of cancer at any site, excluding intestine, and the risk was similar in
both sexes. There may have been some over-reporting of cancer
history in families ofcases. However, in acompanion study on breast
cancer using the same design, study areas and questionnaire, the risk
of breast cancer associated with family history of cancer at any site
excluding breast was close to unity (Negri etal, 1997), and there is no
clear reason why CRC cases should tend to over-report cancer in
relatives more than breast cancer cases. As in hereditary syndromes
involving CRC, such as, for instance, HNPCC, an excess ofa variety
of other cancers has also been reported, conceivably the weak
increase in risk observed may be real. Mortality rates for cancer of
the intestine are much lower in the south ofItaly than in the north (La
Vecchia and Decarli, 1986), and the frequency of HNPCC is also
notably lower in the south (Modica et al, 1995). In our study,
however, the risk offamily history ofintestinal cancer was consistent
across various geographical areas and, if anything, tended to be
higher in the two centres from southem Italy (Latina and Naples),
particularly for colon cancer.
In conclusion, this study provides further information on the
risk of CRC related to a family history of cancer at several sites
and allows a more precise quantification of the risk in different
subsites.
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